French medical regulator HAS said on Thursday it had approved the vaccine developed by Pfizer and BioNTech for France's vaccination rollout, after the European Medicines Agency gave its go-ahead on Monday. 'The vaccine can be used for people aged 16 and over, including elderly,' the regulator says. The European Union is gearing up for a vaccination campaign of unprecedented scale following regulatory approval for the shot. France plans to start its vaccination program on Dec. 27.